The Morning Dispatch: Vaccines on the Horizon

Happy Tuesday! What a day we had yesterday. Our first-ever What’s Next event kicked off (Day 2 starts at 11 a.m.!), Pfizer released incredibly promising data regarding its COVID-19 vaccine, and McDonalds unveiled the McPlant. (Editor: Hmmmm.) What joys will today bring?

Quick Hits: Today’s Top Stories

  • People who were given two doses of the COVID-19 vaccine being developed by Pfizer and BioNTech experienced 90 percent fewer symptomatic COVID-19 cases than those given a placebo, according to an early analysis of Phase 3 trial data released yesterday. Dr. Anthony Fauci called the results “extraordinary.”

  • The FDA issued an emergency-use authorization for bamlanivimab, an antibody therapy from drug manufacturer Eli Lilly that has been used to treat patients with mild to moderate cases of COVID-19.

  • President Trump fired Defense Secretary Mark Esper via tweet yesterday, announcing Director of the National Counterterrorism Center Christopher Miller as his replacement on an acting basis. Esper had reportedly been on the ropes for months after breaking with Trump on the president’s Lafayette Plaza photo-op. 

Try 7 Days Free
Become a Dispatch member for unlimited access to our 10 daily and weekly newsletters, Dispatch Live broadcasts, article comments and community events. JOIN ALREADY A PAID SUBSCRIBER? SIGN IN
Comments (0)
Join The Dispatch to participate in the comments.

There are currently no responses to this article.
Be the first to respond.